{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-037521","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.027401+00:00","generated_at":"2026-06-06T01:17:38.487363+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Quince Therapeutics appoints Rajiv Patni as Class III director","bullets":["Rajiv Patni appointed to board effective Feb 15, 2024 as Class III director, term through 2025 annual meeting.","Receives $38,000 annual retainer plus 54,000-share stock option grant under 2019 Equity Incentive Plan.","Options vest in equal annual installments over 3 years, exercise price equals Feb 15 closing price.","Entered standard indemnification agreement; no family relationships or related party transactions with company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-037521","json":"https://secwatch.observer/filing/0001193125-24-037521.json","markdown":"https://secwatch.observer/filing/0001193125-24-037521.md","text":"https://secwatch.observer/filing/0001193125-24-037521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312524037521/0001193125-24-037521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312524037521/d791068d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T01:17:38.487363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a46b15a58","claim":"Rajiv Patni was appointed as director at Quince Therapeutics, Inc..","evidence_excerpt":"the board of directors (the “ Board ”) of Quince Therapeutics, Inc. (the “ Company ”) appointed Rajiv Patni to serve as a director of the Company, effective as of February 15, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312524037521/0001193125-24-037521-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}